daniel_ezt Profile Banner
Daniel Ezzat Profile
Daniel Ezzat

@daniel_ezt

Followers
46
Following
116
Media
0
Statuses
44

BAEF Research Fellow at Massachusetts General Hospital and Broad Institute of MIT and Harvard

Cambridge, Massachusetts
Joined December 2022
Don't wanna be here? Send us removal request.
@KelvinS_MD
Kelvin Supriami
2 days
Thrilled to share that our study is out now in @ESC_Journals #EJPC! We examined long-term outcomes after coronary angiography among >5,000 individuals with measured lipoprotein(a) [Lp(a)] — one of the most important yet under-recognized drivers of atherosclerotic disease 🫀
7
27
87
@mchonig
Michael Honigberg, MD, MPP
3 days
Excited to share our work @ESC_Journals #EJPC led by @KelvinS_MD @CFAndersenMD w/ @aklfahed Lp(a) + post-cath outcomes in 5,118 🧑‍🤝‍🧑 undergoing cor angio 🫀 @MGHHeartHealth : Lp(a) >=175 nmol/L ➡️ ⬆️ subsequent MI, revasc, ISR, need for PCI after CABG https://t.co/hc0pdKOdky
4
30
103
@KelvinS_MD
Kelvin Supriami
6 days
Insightful session by the amazing @mchonig on pathways from pregnancy to cardiovascular pathology 🫀🤰🧬 We learned that adverse pregnancy outcomes were risk enhancers of future ASCVD risk, highlighting shared mechanisms and prevention opportunities! #AHA25
0
2
11
@KelvinS_MD
Kelvin Supriami
7 days
So grateful for my mentor’s unwavering support and thank you @AHAScience for the opportunity to present our study, an effort to understand atherosclerosis, its trajectory, and disease localization 🫀🧬🏃
@aklfahed
Akl Fahed
8 days
At the Elizabeth Barrett-Connor Research Award for Early Career Investigators #AHA25 @KelvinS_MD shares our work on why people have atherosclerosis in different vascular beds (coronary, cerebrovascular, and peripheral). https://t.co/LbkugqUufY @MGHHeartHealth @broadinstitute
1
2
13
@mchonig
Michael Honigberg, MD, MPP
7 days
Our analysis of CHIP (clonal hematopoiesis of indeterminate potential) and risk of heart failure in ~420,000 @uk_biobank participants led by rising ⭐️ @Sflynn4242 @mghmedres now in @JAMACardio simultaneous w/ #AHA25 https://t.co/OBTznjschl (1/4)
5
28
83
@MitsuakiSawano
Mitsuaki Sawano, MD, PhD, FACC
2 months
📢 #JACCばらん Ep.30「CHIPping the Code: CHIPと心血管リスクの交差点」 🎙️ゲスト:井上 峻輔 先生 @Geno_shun (東京大学大学院 医学系研究科 先端循環器医科学講座 🇯🇵/Editorial執筆) 🔍 今回は Clonal Hematopoiesis of Indeterminate Potential(CHIP) にフォーカス。
4
6
21
@MGBWomenHeart
Mass General Brigham Women's Heart Health Program
3 months
Please join us in congratulating @mchonig!! 👏#weheartourteam
@pnatarajanmd
Pradeep Natarajan
3 months
Major congrats to @mchonig with THREE simultaneous senior-author publications during #ESCCongress25 each with a different first-author from his group! 👏 1️⃣ https://t.co/QNE0mRPIEJ @JACCJournals 2️⃣ https://t.co/lL4U3LogL6 @JACCJournals 3️⃣ https://t.co/oNKAAftAwl @JAMACardio
1
1
14
@mchonig
Michael Honigberg, MD, MPP
3 months
Low-Dose Colchicine May Slow Growth of Clonal Hematopoiesis - American College of Cardiology @NiekMohamma
Tweet card summary image
acc.org
3
4
23
@JGrapsa
Julia Grapsa
3 months
Wonderful exchange of science and terrific lectures by @mchonig @MassGenBrigham and @Borjaibanez1 @CNIC_CARDIO at the 8th MGB transatlantic dialogues @BrighamWomens @RonBlankstein
0
10
41
@WolframPoller
Wolfram Poller
3 months
Fantastic presentation by rising star MGB Heart and Vascular Institute cardiologist @mchonig at the 7th MGB Transatlantic Dialogues meeting at @CNIC_CARDIO with major cardiology legends in attendance! #ESC2025 @MGHHeartHealth @mghcvrc @MGHWomenHeart @broadinstitute @harvardmed
3
4
37
@mchonig
Michael Honigberg, MD, MPP
3 months
@pnatarajanmd
Pradeep Natarajan
3 months
Major congrats to @mchonig with THREE simultaneous senior-author publications during #ESCCongress25 each with a different first-author from his group! 👏 1️⃣ https://t.co/QNE0mRPIEJ @JACCJournals 2️⃣ https://t.co/lL4U3LogL6 @JACCJournals 3️⃣ https://t.co/oNKAAftAwl @JAMACardio
2
8
67
@DrMarthaGulati
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦
3 months
In the special session of research on women/ sex differences includes a trial related to autoimmune disease 📍autoimmune disease associated with ⤴️ CVD risk (35%) 📍some traditional risk factors not as strongly associated with CVD in those with Autoimmune diseases 📍T2DM & CKD
2
22
72
@JAMACardio
JAMA Cardiology
3 months
Among middle-aged adults, clonal hematopoiesis of indeterminate potential (CHIP) was linked to an increased risk of developing myocarditis and pericarditis. 🧵 #ESCCongress #WCCardio https://t.co/5OcuKJVKPr
1
4
13
@artschuermans
Art Schuermans
3 months
Does clonal hematopoiesis of indeterminate potential (CHIP) predict heart inflammation? Thrilled to share our work identifying CHIP as a risk factor for myo-/pericarditis, with the amazing @mchonig Simultaneous pub with #ESC2025 in @JAMACardio https://t.co/GFroe0r7wE (1/x)
4
26
74
@JAMACardio
JAMA Cardiology
3 months
Editorial: Schuermans et al's study links clonal hematopoiesis (CHIP) to acute inflammatory heart conditions, suggesting that CHIP mutations could serve as key biomarkers for predisposition to chronic and acute cardiac diseases. #ESCCongress #WCCardio https://t.co/hQ4HsYBGZB
0
3
6
@EricTopol
Eric Topol
3 months
New report that CHIP (clonal hematopoiesis of indeterminate potential, blood stem cell clones that increase with age) is an independent risk factor for myocarditis and pericarditis, promoting inflammation #ESC2025 @JAMA_current https://t.co/spxhWqXqNH
3
41
130
@ACCinTouch
American College of Cardiology
3 months
📺 ACC Anywhere TV From ESC Congress 2025 Quick Take: Dr. @mchonig discusses clonal hematopoiesis of indeterminate potential (CHIP) & CV risk with results from both the Women’s Health Initiative Long Life Study & LoDoCo2 trial substudy, simultaneously published in #JACC.
0
2
5
@yash_pershad
Yash Pershad
3 months
Longitudinal analysis of the LoDoCo2 clinical trial suggests that colchicine blunts TET2 CHIP expansion possibly mediated by reductions in IL-6! These results add to a growing body of evidence that colchicine and IL-6R blockers may be beneficial for CHIP-associated CVD...
@JACCJournals
JACC Journals
3 months
In this exploratory analysis, Tx w/ low-dose colchicine was assoc w/ an attenuated annual clonal growth in TET2 CH. Findings suggest potential for colchicine to curb proliferative advantage of key CH driver mutations https://t.co/QipRX2Dn6U #ESCCongress #WCCardio #JACC @mchonig
2
10
40
@mchonig
Michael Honigberg, MD, MPP
3 months
@daniel_ezt presenting his work simultaneously published in @JACCJournals #JACC at #ESC2025 @escardio https://t.co/iTZGizylr2
@mchonig
Michael Honigberg, MD, MPP
3 months
The lab's first sim pub of #ESC2025 is now online in @JACCJournals #JACC ! https://t.co/iTZGizylr2 Led by 🇧🇪⭐️ @daniel_ezt , we examined clonal hematopoiesis (CHIP) 🩸 & cardiovascular 🫀 outcomes in older women 👵 using deep targeted 🧬 sequencing in the @WHIStudy 👇 (1/X)
0
4
15